Mitochondrial DNA variation in sudden cardiac death: a population-based study

Area of Science:

• Genetics
• Cardiology
• Mitochondrial Diseases

Background:

• Cardiomyopathy and cardiac conduction defects are common in mitochondrial diseases.
• Sudden cardiac death (SCD) can be the initial presentation of mitochondrial disease, even in asymptomatic individuals with cardiac mitochondrial DNA (mtDNA) mutations.

Purpose of the Study:

• To investigate the role of pathogenic mtDNA point mutations and haplogroups in the cardiac muscle of individuals who died from non-ischaemic SCD.
• To determine if specific mtDNA variations are associated with an increased risk of non-ischaemic SCD in a Finnish cohort.

Main Methods:

• Analysis of cardiac muscle DNA from 280 Finnish subjects who died from non-ischaemic SCD and 537 population controls.
• Sequencing to identify pathogenic mtDNA point mutations and haplogroup analysis.

Main Results:

• No common or novel pathogenic mtDNA point mutations were identified in the SCD cohort.
• Haplogroup H1 was found at a higher frequency in the SCD subjects compared to population controls (OR: 1.76, 95% CI: 1.02-3.04).

Conclusions:

• Pathogenic point mutations in mtDNA are not a significant population-level contributor to non-ischaemic SCD.
• Natural genetic variation within mtDNA, such as haplogroup H1, may play a role in modifying the risk of sudden cardiac death.